SecBot SecBot
SECBOTREPLAY Home › Report › LRMR

LRMR · Insiders buy after BLA filing

Larimar Therapeutics, Inc. · CLUSTER filed Nov 12, 2026 at 18:00 ET

At the news

BULLISHIMPACT 4/10

CLUSTER filed Nov 12, 2026 at 18:00 ET

Multiple Larimar Therapeutics insiders, including the CEO, CFO, President/COO, and directors, made open-market purchases totaling approximately $382K in the week following the company's BLA submission for nomlabofusp. The cluster represents about 0.13% of market cap, a modest but notable signal of insider confidence after a major regulatory milestone.

  • Seven insiders purchased shares in a 7-day window (Nov 11-12, 2026)
  • Total open-market purchases: ~$382K across all seven insiders
  • CEO Carole Ben-Maimon purchased $50K worth of shares
  • CFO Michael Celano purchased $50K worth of shares

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access